Latest News about IMUX
Recent news which mentions IMUX
From Benzinga
From Benzinga
52 Biggest Movers From Yesterday
February 02, 2022
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
February 01, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 01, 2022
From Benzinga
Mid-Morning Market Update: Markets Mostly Lower Following Monday's Rally; UPS Earnings Top Views
February 01, 2022
From Benzinga
60 Biggest Movers From Yesterday
January 11, 2022
From Benzinga
61 Biggest Movers From Yesterday
January 04, 2022
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
January 03, 2022
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
Immunic, University Medical Center Goettingen Ink Licensing Pact For Combination Viral Infection Treatments
September 22, 2021
Tickers
IMUX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 22, 2021
From Benzinga
10 Biggest Price Target Changes For Tuesday
September 07, 2021
From Benzinga
84 Biggest Movers From Friday
August 09, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 06, 2021
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 05, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
July 16, 2021
From Benzinga
54 Biggest Movers From Yesterday
July 16, 2021
From Benzinga
Why Immunic Plummeted by 21% on Thursday
July 15, 2021
From Motley Fool
From Benzinga
32 Stocks Moving In Thursday's Mid-Day Session
July 15, 2021
From Benzinga
Immunic Stock Is Trading Lower After Equity Raise Of $45M To Fund Lead Pipeline Candidates
July 15, 2021
Tickers
IMUX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.